Alliance Medical Group Limited (‘AMGL’) is the holding company for a group of companies that operates in a number of countries including the UK. AMGL does not trade itself; the business in the UK is operated by Alliance Medical Limited and its subsidiary companies.
This statement is made pursuant to Section 54, Part 6 of the Modern Slavery Act 2015 (the ‘Act’) and sets out the steps taken to ensure that slavery and human trafficking is not taking place within either its UK business or the supply chains to that business.
Alliance Medical Limited is a provider of complex medical imaging services, and has provided those services for more than 30 years. We also manufacture and distribute radiopharmaceutical products. We work collaboratively with clinicians, public and private health care organisations and academic institutions to
provide high quality and cost effective imaging services and radiopharmaceuticals to our customers and for our patients.
Our supply chains include procurement of scanning equipment and associated information technology equipment, transportation of mobile scanning units and radiopharmaceuticals, agency staff, medical and non-medical consumables, and construction and maintenance of buildings.
We are committed to ensuring that there is no modern slavery within our own business or in our supply chains.
We operate employment policies and procedures that are designed to treat all individuals who work within our business with dignity and respect, to reward them fairly for their work and not to exploit them. We only wish to work with organisations in our supply chains that have a similar commitment and are not involved in modern slavery. While it is the obligation of those organisations to operate their own policies and procedures to achieve that objective, we will continue to build upon our existing good practice to ensure we take all reasonable steps to verify compliance by all material direct suppliers with the Act.
Summary of initial activities
We have carried out an initial high level assessment of our supply chains and the potential for slavery and human trafficking. As the vast majority of our suppliers are based in the UK and many are operating in specialised rather than low skilled industries, our supply chains have been assessed overall as posing a low risk in terms of non-compliance with the Act.
Activities to be undertaken in the next 12 months
- A more detailed risk assessment of material direct suppliers will be undertaken;
- The introduction of contractual clauses – the Company will be drafting and introducing standard contract clauses that will require compliance with the Act; and
- Training will to be developed and delivered to all appropriate personnel, targeting those areas of the business which the Company identifies as posing the greatest risk from a slavery or human trafficking perspective.
Approval by Alliance Medical Group Limited’s and Alliance Medical Limited’s Board of Directors
This statement for the financial year ending 31th March 2016 has been approved by the board of directors of each of Alliance Medical Group Limited and Alliance Medical Limited.
Chief Executive Officer